Clinical research on a new progestagen (norgestrel) combined with ethinyl estradiol
Murray, E.; Bosch, L.R.; Lema, B.E.
Prensa Medica Argentina 57(31): 1485-1494
1970
ISSN/ISBN: 0032-745X PMID: 5485488 Document Number: 20185
Document emailed within 1 workday
Related Documents
Galán, G.; Gayán, P.; Tisné, L. 1985: Laboratory and clinical study with a new progestagen combined with ethinyl estradiol used in contraception Revista Chilena de Obstetricia y Ginecologia 50(4): 317-324Galán, G.; Gayán, P.; Tisné, L. 1985: Laboratory and clinical study with a new progestagen combined with ethinyl estradiol used in contraception Revista Chilena de Obstetricia y Ginecologia 50(4): 317-324
Krishnan, S.; Kiley, J. 2010: The lowest-dose, extended-cycle combined oral contraceptive pill with continuous ethinyl estradiol in the United States: a review of the literature on ethinyl estradiol 20 μg/levonorgestrel 100 μg + ethinyl estradiol 10 μg International Journal of Women's Health 2: 235-239
Korba, V.D.; Heil, C.G. 1975: Eight years of fertility control with norgestrel-ethinyl estradiol (Ovral): an updated clinical review Fertility and Sterility 26(10): 973-981
Lévrier, M. 1970: Clinical study and effect on the uterine receptor of the combination Norgestrel-Ethinyl-Estradiol (FH 122-A) in 500 menstrual cycles Bordeaux Medical 3(1): 225-226
Oner, G.; Muderris, I.I. 2011: A prospective randomized trial comparing low-dose ethinyl estradiol and drospirenone 24/4 combined oral contraceptive vs. ethinyl estradiol and drospirenone 21/7 combined oral contraceptive in the treatment of hirsutism Contraception 84(5): 508-511
Oride, A.; Kanasaki, H.; Miyazaki, K. 2014: Disappearance of a uterine arteriovenous malformation following long-term administration of oral norgestrel/ethinyl estradiol Journal of Obstetrics and Gynaecology Research 40(6): 1807-1810
Akerlund, M. 1997: Clinical experience of a combined oral contraceptive with very low dose ethinyl estradiol Acta Obstetricia et Gynecologica Scandinavica. Suppl 164: 63-65
DelConte, A.; Loffer, F.; Grubb, G.S. 1999: Cycle control with oral contraceptives containing 20 micrograms of ethinyl estradiol. a multicenter, randomized comparison of levonorgestrel/ethinyl estradiol (100 micrograms/20 micrograms) and norethindrone/ethinyl estradiol (1000 micrograms/20 micrograms) Contraception 59(3): 187-193
Molina, R.C.; Sandoval, J.Z.; Montero, A.V.; Oyarzún, P.G.; Molina, T.ís.G.; González, E.A. 2009: Comparative performance of a combined injectable contraceptive (50 mg norethisterone enanthate plus 5mg estradiol valerate) and a combined oral contraceptive (0.15 mg levonorgestrel plus 0.03 mg ethinyl estradiol) in adolescents Journal of Pediatric and Adolescent Gynecology 22(1): 25-31
McBride, W.G. 1970: D-norgestrel combined with ethinyl oestradiol as an oral contraceptive Current Therapeutic Research 12(4): 177-185
Gaussem, P.; Alhenc-Gelas, M.; Thomas, J.-L.; Bachelot-Loza, C.; Remones, V.; Ali, F.D.; Aiach, M.; Scarabin, P.-Y. 2011: Haemostatic effects of a new combined oral contraceptive, nomegestrol acetate/17β-estradiol, compared with those of levonorgestrel/ethinyl estradiol. a double-blind, randomised study Thrombosis and Haemostasis 105(3): 560-567
Kriplani, A.; Periyasamy, A.J.; Agarwal, N.; Kulshrestha, V.; Kumar, A.; Ammini, A.C. 2010: Effect of oral contraceptive containing ethinyl estradiol combined with drospirenone vs. desogestrel on clinical and biochemical parameters in patients with polycystic ovary syndrome Contraception 82(2): 139-146
Klipping, C.; Marr, J. 2005: Effects of two combined oral contraceptives containing ethinyl estradiol 20 μg combined with either drospirenone or desogestrel on lipids, hemostatic parameters and carbohydrate metabolism Contraception (Stoneham) 71(6): 409-416
Kashanian, M.; Shahpourian, F.; Zare, O. 2010: A comparison between monophasic levonorgestrel-ethinyl estradiol 150/30 and triphasic levonorgestrel-ethinyl estradiol 50-75-125/30-40-30 contraceptive pills for side effects and patient satisfaction: a study in Iran European Journal of Obstetrics Gynecology and Reproductive Biology 150(1): 47-51
Creinin, M.D.; Lippman, J.S.; Eder, S.E.; Godwin, A.J.; Olson, W. 2002: The effect of extending the pill-free interval on follicular activity: triphasic norgestimate/35 micro g ethinyl estradiol versus monophasic levonorgestrel/20 micro g ethinyl estradiol Contraception 66(3): 147-152
Kroll, R.; Ackerman, R.; Feldman, R.; Howard, B.; Weiss, H.; Hsieh, J.; Ricciotti, N. 2016: Efficacy and safety of a 21/7-active combined oral contraceptive with continuous low-dose ethinyl estradiol Contraception 93(3): 249-256
Bifano, M.; Sevinsky, H.; Hwang, C.; Kandoussi, H.; Jiang, H.; Grasela, D.; Bertz, R. 2014: Effect of the coadministration of daclatasvir on the pharmacokinetics of a combined oral contraceptive containing ethinyl estradiol and norgestimate Antiviral Therapy 19(5): 511-519
Bjarnadóttir, R.I.; Tuppurainen, M.; Killick, S.R. 2002: Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel/ethinyl estradiol American Journal of Obstetrics and Gynecology 186(3): 389-395
Bergstein, N.A.M. 1977: Investigation of a new low dose oral contraceptive 30 micrograms ethynyl estradiol and 150 micrograms levo norgestrel dextro norgestrel Clinical Therapeutics 1(1): 26-32